Adeptus Health (ADPT) Stock: Weak On High Volume Today

Trade-Ideas LLC identified Adeptus Health (ADPT) as a weak on high relative volume candidate
By TheStreet Wire ,

Trade-Ideas LLC identified

Adeptus Health

(

ADPT

) as a weak on high relative volume candidate. In addition to specific proprietary factors, Trade-Ideas identified Adeptus Health as such a stock due to the following factors:

  • ADPT has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $26.2 million.
  • ADPT has traded 77,260 shares today.
  • ADPT is trading at 2.48 times the normal volume for the stock at this time of day.
  • ADPT is trading at a new low 4.05% below yesterday's close.

'Weak on High Relative Volume' stocks are worth watching because major volume moves tend to indicate underlying activity such as material stock news, analyst downgrades, insider selling, selling from 'superinvestors,' or that hedge funds and traders are piling out of a stock ahead of a catalyst. Regardless of the impetus behind the price and volume action, when a stock moves with strength and volume it can indicate the start of a new trend on which early investors can capitalize (or avoid losses by trimming weak positions). In the event of a well-timed trading opportunity, combining technical indicators with fundamental trends and a disciplined trading methodology should help you take the first steps towards investment success.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in ADPT with the Ticky from Trade-Ideas. See the FREE profile for ADPT NOW at Trade-Ideas

More details on ADPT:

Adeptus Health Inc. owns and operates a network of independent freestanding emergency rooms in the United States. As of December 31, 2015, it operated 81 facilities located in the Houston, Dallas/Fort Worth, San Antonio, Austin, Colorado Springs, Denver, and Phoenix. ADPT has a PE ratio of 42. Currently there are 4 analysts that rate Adeptus Health a buy, no analysts rate it a sell, and 1 rates it a hold.

The average volume for Adeptus Health has been 563,400 shares per day over the past 30 days. Adeptus Health has a market cap of $1.2 billion and is part of the health care sector and health services industry. The stock has a beta of 0.83 and a short float of 77.5% with 15.67 days to cover. Shares are up 4.7% year-to-date as of the close of trading on Friday.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

TheStreetRatings.com

Analysis:

TheStreet Quant Ratings

rates Adeptus Health as a

hold

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, notable return on equity and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself, premium valuation and generally higher debt management risk.

Highlights from the ratings report include:

  • The revenue growth came in higher than the industry average of 8.8%. Since the same quarter one year prior, revenues rose by 38.4%. Growth in the company's revenue appears to have helped boost the earnings per share.
  • ADEPTUS HEALTH INC reported significant earnings per share improvement in the most recent quarter compared to the same quarter a year ago. The company has demonstrated a pattern of positive earnings per share growth over the past year. We feel that this trend should continue. This trend suggests that the performance of the business is improving. During the past fiscal year, ADEPTUS HEALTH INC turned its bottom line around by earning $1.17 versus -$0.35 in the prior year. This year, the market expects an improvement in earnings ($2.62 versus $1.17).
  • ADPT's stock share price has done very poorly compared to where it was a year ago: Despite any rallies, the net result is that it is down by 38.43%, which is also worse that the performance of the S&P 500 Index. Investors have so far failed to pay much attention to the earnings improvements the company has managed to achieve over the last quarter. Despite the heavy decline in its share price, this stock is still more expensive (when compared to its current earnings) than most other companies in its industry.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Loading ...